Streetbeat News

IONQ

IonQ, Inc.

https://www.ionq.com

Industry

Computer Hardware

IonQ, Inc. engages in the development of general-purpose quantum computing systems. It sells access to quantum computers with 20 qubits. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services' (AWS) Amazon Braket, Microsoft's Azure Quantum, and Google's Cloud Marketplace, as well as through its cloud service. IonQ, Inc. was founded in 2015 and is headquartered in College Park, Maryland.

Open

21.69

Mkt cap

5.3B

Volume

64M

High

25.68

P/E Ratio

-30.23

52-wk high

25.68

Low

21.31

Div yield

N/A

52-wk low

6.22

Autoliv reported strong sales, leading to a 5.5% stock increase. Other stocks like Oklo, Peloton, and Netflix also saw gains due to various positive developments.

Portfolio Pulse from Avi Kapoor

October 18, 2024 | 2:49 pm

The article highlights unusual options activity for several information technology stocks, indicating potential trading opportunities. Notable mentions include NVDA, AAPL, SMCI, MSFT, MU, IONQ, WULF, MVIS, AMD, and GDS, with varying bullish and bearish sentiments.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 5:35 pm

IonQ Inc (NYSE:IONQ) shares are experiencing volatility after announcing a significant milestone in quantum networking. The company successfully demonstrated remote ion-ion entanglement, marking progress in its scaling strategy. This follows a recent $54.5 million contract with the U.S. Air Force Research Lab and a forecast to nearly double its revenue for the third consecutive year.

Portfolio Pulse from Adam Eckert

October 03, 2024 | 9:25 pm

IonQ has achieved a significant milestone in quantum computing by demonstrating remote ion-ion entanglement, marking progress towards scalable quantum systems. This is the second of four milestones needed for developing photonic interconnects, crucial for quantum networking.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 8:02 pm

IonQ (NYSE:IONQ) has received mixed analyst ratings over the past three months, with a majority being bullish. The average 12-month price target has decreased by 21.98% to $12.0. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. IonQ has shown impressive revenue growth but struggles with profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 12:01 pm

Needham analyst Quinn Bolton has reiterated a Buy rating on IonQ (NYSE:IONQ) and maintained a price target of $13.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 9:31 am

U.S. stocks showed mixed performance with the Nasdaq Composite falling over 100 points. Energy shares rose by 1.3%, while information technology shares fell by 1%. Onconetix shares surged 56% following a significant stake report by Altos Venture. IonQ shares increased 16% after securing a $54.5 million contract with the U.S. Air Force Research Lab. Rocket Lab USA shares rose 12% after a price target increase by Keybanc. Seelos Therapeutics and enVVeno Medical Corporation shares fell significantly due to company-specific announcements.

Portfolio Pulse from Avi Kapoor

September 27, 2024 | 6:41 pm

The article highlights the intraday movements of several information technology stocks on Friday. Notable gainers include OneConnect Financial Tech, Aurora Mobile, and IonQ, while significant losers include Intchains Gr and MeridianLink.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 4:31 pm

IonQ, Inc. (NYSE:IONQ) shares surged after securing a $54.5 million contract with the US Air Force Research Lab. The company has shown significant growth in sales and revenue, with $72.8 million in bookings year-to-date. IonQ is confident in meeting its annual guidance and has also announced a $9 million agreement with the University of Maryland. Despite a 43% stock decline over the past year, IonQ's recent developments have positively impacted its stock price.

Portfolio Pulse from Nabaparna Bhattacharya

September 27, 2024 | 4:25 pm

U.S. stocks showed mixed performance with the Dow Jones rising, while the NASDAQ and S&P 500 fell. The PCE Price Index increased less than expected, impacting inflation expectations. IonQ, Onconetix, and Biomea Fusion saw significant stock gains due to positive company news, while Seelos Therapeutics, enVVeno Medical, and Acadia Healthcare experienced declines due to various challenges.

Portfolio Pulse from Avi Kapoor

September 27, 2024 | 4:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.